| Parent Drug Name | Name of Impurity | Catalogue No. | |
|---|---|---|---|
| Cabergoline | Cabergoline EP Impurity A | VE0013122 | View CAS 81409-74-7 |
| Cabergoline | Cabergoline EP Impurity B | VE0013124 | View CAS 166533-36-4 |
| Cabergoline | Cabergoline EP Impurity C | VE0013125 | View CAS 126554-50-5 |
| Cabergoline | Cabergoline EP Impurity D | VE0013126 | View CAS 85329-86-8 |
| Cabergoline | Cabergoline Isomer-D6 | DVE00274 | View |
| Cabergoline | Cabergoline N-Oxide | VE0013127 | View |
[rfq_list]
| Catalogue No. | VE0013125 |
| CAS No. | 126554-50-5 |
| Molecular Formula | C29H42N6O3 |
| Molecular Weight | 522.69 g/mol |
| Parent drug | Cabergoline |
| IUPAC Name | (6aR, 9R, 10aR)-N9-[3-(dimethylamino)propyl]-N4-ethyl- N9-(ethylcarbamoyl)-7-(prop-2-enyl)-6a, 7, 8, 9, 10, 10ahexahydroindolo[ 4, 3-fg]quinoline-4, 9(6H)-dicarboxamide |
| Synonyms | Cabergoline Related Compound C |
| Smiles | – |
| References | – |
| Status | In-stock |
| ListName | Cabergoline EP Impurity C |
| Exclusively Supplied by Veeprho | Exclusively Supplied by Veeprho |
"*" indicates required fields
